These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 21788592)

  • 1. Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association.
    Weintraub WS; Daniels SR; Burke LE; Franklin BA; Goff DC; Hayman LL; Lloyd-Jones D; Pandey DK; Sanchez EJ; Schram AP; Whitsel LP; ; ; ; ; ; ; ;
    Circulation; 2011 Aug; 124(8):967-90. PubMed ID: 21788592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying favorable-value cardiovascular health services.
    Braithwaite RS; Mentor SM
    Am J Manag Care; 2011 Jun; 17(6):431-8. PubMed ID: 21756013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association.
    Eyre H; Kahn R; Robertson RM; Clark NG; Doyle C; Hong Y; Gansler T; Glynn T; Smith RA; Taubert K; Thun MJ; ; ;
    Circulation; 2004 Jun; 109(25):3244-55. PubMed ID: 15198946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for cardiovascular disease prevention: importance of public and community health programs.
    Egan BM; Lackland DT
    Ethn Dis; 1998; 8(2):228-39. PubMed ID: 9681288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiovascular risk factors and prevention in women: similarities and differences].
    Sclavo M
    Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise and acute cardiovascular events placing the risks into perspective: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Cardiology.
    Thompson PD; Franklin BA; Balady GJ; Blair SN; Corrado D; Estes NA; Fulton JE; Gordon NF; Haskell WL; Link MS; Maron BJ; Mittleman MA; Pelliccia A; Wenger NK; Willich SN; Costa F; ; ;
    Circulation; 2007 May; 115(17):2358-68. PubMed ID: 17468391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The PreFord Study. A prospective cohort study to evaluate the risk of a cardiovascular event (overall-collective) as well as a prospective, randomized, controlled, multicentre clinical intervention study (high-risk-collective) on primary prevention of cardiovascular diseases in the Ford Motor Company employees in Germany].
    Gysan DB; Latsch J; Bjarnason-Wehrens B; Albus C; Falkowski G; Herold G; Mey E; Heinzler R; Montiel G; Schneider CA; Stützer H; Türk S; Weisbrod M; Predel HG
    Z Kardiol; 2004 Feb; 93(2):131-6. PubMed ID: 14963679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is prevention a fantasy, or the future of medicine? A panoramic view of recent data, status, and direction in cardiovascular prevention.
    Kones R
    Ther Adv Cardiovasc Dis; 2011 Feb; 5(1):61-81. PubMed ID: 21183531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
    Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
    Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of intensive atorvastatin treatment in high-risk patients compared with usual care in a postgeneric statin market: economic analysis of the Aggressive Lipid-lowering Initiation Abates New Cardiac Events (ALLIANCE) study.
    Mullins CD; Rattinger GB; Kuznik A; Koren MJ
    Clin Ther; 2008; 30 Pt 2():2204-16. PubMed ID: 19281915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screen-and-treat strategies for albuminuria to prevent cardiovascular and renal disease: cost-effectiveness of nationwide and targeted interventions based on analysis of cohort data from the Netherlands.
    Boersma C; Gansevoort RT; Pechlivanoglou P; Visser ST; van Toly FF; de Jong-van den Berg LT; de Jong PE; Postma MJ;
    Clin Ther; 2010 Jun; 32(6):1103-21. PubMed ID: 20637965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of aspirin treatment in the primary prevention of cardiovascular disease events in subgroups based on age, gender, and varying cardiovascular risk.
    Greving JP; Buskens E; Koffijberg H; Algra A
    Circulation; 2008 Jun; 117(22):2875-83. PubMed ID: 18506010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].
    Rev Esp Salud Publica; 2000; 74(3):215-53. PubMed ID: 10918811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of an article: aspirin for primary prevention of cardiovascular events in people with diabetes. A position statement of the American Diabetes Association (ADA), a scientific statement of the American Heart Association(AHA), and an expert consensus document of the American College of Cardiology Foundation (ACCF). Diabetes Care, 33:6; June 2010; 1395-1402.
    Gilpin VL; ; ;
    J Vasc Nurs; 2010 Dec; 28(4):154-5. PubMed ID: 21074118
    [No Abstract]   [Full Text] [Related]  

  • 17. Socioeconomic considerations in the primordial prevention of cardiovascular disease.
    Kaplan GA; Lynch JW
    Prev Med; 1999 Dec; 29(6 Pt 2):S30-5. PubMed ID: 10641815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics.
    Kavey RE; Allada V; Daniels SR; Hayman LL; McCrindle BW; Newburger JW; Parekh RS; Steinberger J; ; ; ; ; ; ; ;
    Circulation; 2006 Dec; 114(24):2710-38. PubMed ID: 17130340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular health among American Indians and Alaska Natives: successes, challenges, and potentials.
    Galloway JM
    Am J Prev Med; 2005 Dec; 29(5 Suppl 1):11-7. PubMed ID: 16389120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevention of cardiovascular disease: have we really made progress?
    Pearson TA
    Health Aff (Millwood); 2007; 26(1):49-60. PubMed ID: 17211013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.